We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Noninvasive Device Estimates Blood Sugar

By LabMedica International staff writers
Posted on 30 Nov 2011
Print article
Glucose levels from tears could accurately measure blood glucose (sugar) levels using an electrochemical sensor device.

A novel pain-free device is under development that could detect tear-glucose levels, rather than having to go through the cumbersome and sometimes painful routine of drawing blood

At the University of Michigan (Ann Arbor, MI, USA), scientists have developed an amperometric needle-type electrochemical glucose sensor intended for tear glucose measurements. It is used in conjunction with a capillary tube to collect microliter volumes of tear fluid. The glucose sensor was employed to measure tear-glucose levels in anesthetized rabbits over an eight-hour period while also measuring the blood glucose values.

The sensor was calibrated in capillary tubes with 100-µM glucose in the middle of the 8-hour experiment. Every 30 minutes, 0.6 mL of blood was drawn and the blood glucose level was measured using a Radiometer ABL 725 blood analyzer (Radiometer America Inc., Westlake, OH, USA) that employs a macro-electrochemical enzyme electrode to quantitate blood glucose. At the same time, 5 µL of rabbit tear fluid was collected in the capillary and the current from the glucose in the tear fluid was recorded using the tear glucose sensor.

The sensor was extremely sensitive and can achieve extremely low detection limits of 1.5 ± 0.4 µM of glucose. This is enough to measure tear-fluid glucose levels, with a glucose sensitivity of 0.032 ± 0.02 nA/µM. The sensor's capillary tube only requires 4-5 µL of tear fluid when the needle sensor is inserted into the capillary. A strong correlation between tear and blood glucose levels was found, suggesting that measurement of tear glucose is a potential noninvasive substitute for blood glucose measurements, and the new sensor configuration could aid in conducting further investigations in this direction.

Patients with diabetes may have to draw blood from about two to ten times daily to test their blood glucose levels. A considerable number of diabetics do not draw blood as often as they should, because of the discomfort and pain it causes. This may lead to poor glycemic control. Long-term poor glycemic control increases several risks and complications linked to the condition, especially microvascular complications which can lead to neuropathy and the development of foot ulcers, retinopathy and other diseases and conditions. The study was published on September 30, 2011, in the journal Analytical Chemistry.

Related Links:
University of Michigan
Radiometer America Inc.


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.